Overview

Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer

Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label randomized clinical study comparing primary prostate cryoablation alone (No-ADT group) with cryoablation plus short-term adjuvant androgen-deprivation therapy (Adj-ADT group) in the treatment of patients with high-risk localized prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Androgens
Ascorbic Acid
Estrogens, Conjugated (USP)
Hormones
Methyltestosterone